A single line often inverts meaning once you see what it
answers, so neighbouring messages are always shown.
-
Oh, the paper, generally, I disagreed with the idea that you could completely rule out the lab leak, and actually wrote a commentator, commentory piece -- what's the word?
-
Commentary.
-
Thanks. A commentary piece that was published in Immunity, May 2020, that stated, equivocally, DC.Scheduling@LexitasLegal.com that it is unlikely that the lab leak hypothesis will go away because the safety procedures at the WIV, and I cited their paper where they worked with viruses at BSL-2.
-
Have you ever done any gain-of-function work for DARPA?
-
2026-04-10 09:00
Ralph S. Baric
For DARPA? No.
-
For DoD?
-
No.
-
For any other Federal agency?
-
Besides the NIH? I mean, technically, the work that we did with MERS, where we were given a waiver, as far as I know it was never really reviewed for GOF. It decided that it was in the national interest to develop a mouse model so that countermeasures could be developed against MERS. The virus has a 35 percent mortality rate. It could transmit to people, and it could transmit through asymptomatic spread. So there's a threat potential there. I think NIH made the right call in that case, that you develop the appropriate reagents so that you can move countermeasures forward to protect the public.